Stockreport

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Insulet Corporation  (PODD) 
Last insulet corporation earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.insulet.com/investor-relations
PDF First randomized controlled trial to evaluate direct transition from multiple daily injections to automated insulin delivery in adults and children with type 1 diabetes [Read more]